Skip to content

Clinical trials

Phase 2 trials in Ecuador

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Ecuador Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20141
20151
20161
20171
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Atea Pharmaceuticals, Inc.1
Aurinia Pharmaceuticals Inc.1
Catalysis SL1
EmeraMed1
GlaxoSmithKline1
National Institute of Allergy and Infectious Diseases (NIAID)1
Universidad San Francisco de Quito1
Vaxart1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Virus Diseases3
Autism Spectrum Disorder1
COVID-191
Condylomata Acuminata1
Dengue1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Flaviviridae Infections1
Flavivirus Infections1
Heart Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.